TAM Receptor Inhibition–Implications for Cancer and the Immune System
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TAM Receptor Inhibition–Implications for Cancer and the Immune System
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 6, Pages 1195
Publisher
MDPI AG
Online
2021-03-11
DOI
10.3390/cancers13061195
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP
- (2020) Yi Zhou et al. IMMUNITY
- AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells
- (2020) Maria L. Lotsberg et al. Journal of Thoracic Oncology
- Blockade of Stromal Gas6 Alters Cancer Cell Plasticity, Activates NK Cells, and Inhibits Pancreatic Cancer Metastasis
- (2020) Lucy Ireland et al. Frontiers in Immunology
- Targeting MerTK Enhances Adaptive Immune Responses After Radiation Therapy
- (2020) Garth W. Tormoen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system
- (2020) Justus Huelse et al. PHARMACOLOGY & THERAPEUTICS
- Implications of the Receptor Tyrosine Kinase Axl in Gastric Cancer Progression
- (2020) Lirui He et al. OncoTargets and Therapy
- AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
- (2019) Hirokazu Taniguchi et al. Nature Communications
- Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib via STAT5- and hypoxia- dependent up-regulation of AXL
- (2019) Pierre-Yves Dumas et al. HAEMATOLOGICA
- Pan-TAM tyrosine kinase inhibitor BMS-777607 enhances anti-PD-1 mAb efficacy in a murine model of triple-negative breast cancer
- (2019) Canan Kasikara et al. CANCER RESEARCH
- Immuno-Oncological Efficacy of RXDX-106, a Novel Small Molecule Inhibitor of the TAM (TYRO3, AXL, MER) Family of Kinases
- (2019) Yumi Yokoyama et al. CANCER RESEARCH
- Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
- (2019) Kayla V. Myers et al. Molecular Cancer
- Targeting of the AXL receptor tyrosine kinase by small molecule inhibitor leads to AXL cell surface accumulation by impairing the ubiquitin-dependent receptor degradation
- (2019) Markus Lauter et al. Cell Communication and Signaling
- Axl Inhibitor R428 Enhances TRAIL-Mediated Apoptosis Through Downregulation of c-FLIP and Survivin Expression in Renal Carcinoma
- (2019) Seon Min Woo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells
- (2019) Marlies J.W. Peeters et al. Cancer Immunology Research
- Type I Interferon Receptor on NK Cells Negatively Regulates Interferon-γ Production
- (2019) Amanda J. Lee et al. Frontiers in Immunology
- Triple Therapy with MerTK and PD1 Inhibition plus Radiotherapy Promotes Abscopal Antitumor Immune Responses
- (2019) Mauricio S. Caetano et al. CLINICAL CANCER RESEARCH
- TAM receptors attenuate murine NK‐cell responses via E3 ubiquitin ligase Cbl‐b
- (2019) Leilani M. Chirino et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity
- (2019) Stéphane Terry et al. Cancer Immunology Research
- TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti–PD-1 Therapy in Melanoma
- (2019) Alisha Holtzhausen et al. Cancer Immunology Research
- TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
- (2019) Marlies J. W. Peeters et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The prognostic role of Gas6/Axl axis in solid malignancies: a meta-analysis and literature review
- (2018) Sheng Zhang et al. OncoTargets and Therapy
- Axl Involved in Mineral Trioxide Aggregate Induces Macrophage Polarization
- (2018) Hsiao-Wen Yeh et al. JOURNAL OF ENDODONTICS
- AXL Mediates Esophageal Adenocarcinoma Cell Invasion through Regulation of Extracellular Acidification and Lysosome Trafficking
- (2018) Selma Maacha et al. NEOPLASIA
- Inhibition of MERTK promotes suppression of tumor growth in BRAF mutant and BRAF wild-type melanoma
- (2018) Lenka Sinik et al. MOLECULAR CANCER THERAPEUTICS
- Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer
- (2018) Jeanne M. Quinn et al. MOLECULAR CANCER THERAPEUTICS
- Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression
- (2017) Canan Kasikara et al. MOLECULAR CANCER RESEARCH
- Axl inhibition induces the antitumor immune response which can be further potentiated by PD-1 blockade in the mouse cancer models
- (2017) Zhiqiang Guo et al. Oncotarget
- PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
- (2017) Sylvain Simon et al. OncoImmunology
- UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models
- (2016) Deborah DeRyckere et al. CLINICAL CANCER RESEARCH
- The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer
- (2016) J. Antony et al. Science Signaling
- The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer
- (2016) J. Antony et al. Science Signaling
- TAM Receptor Signaling in Immune Homeostasis
- (2015) Carla V. Rothlin et al. Annual Review of Immunology
- MERTK as negative regulator of human T cell activation
- (2015) Raquel Cabezo´n et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Viral apoptotic mimicry
- (2015) Ali Amara et al. NATURE REVIEWS MICROBIOLOGY
- Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia
- (2015) Alisa B. Lee-Sherick et al. Oncotarget
- Axl as a mediator of cellular growth and survival
- (2015) Haley Axelrod et al. Oncotarget
- The Mertk receptor tyrosine kinase promotes T–B interaction stimulated by IgD B-cell receptor cross-linking
- (2014) Wen-Hai Shao et al. JOURNAL OF AUTOIMMUNITY
- Overexpression of MERTK Receptor Tyrosine Kinase in Epithelial Cancer Cells Drives Efferocytosis in a Gain-of-Function Capacity
- (2014) Khanh-Quynh N. Nguyen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
- (2014) Magdalena Paolino et al. NATURE
- Diversification of TAM receptor tyrosine kinase function
- (2014) Anna Zagórska et al. NATURE IMMUNOLOGY
- Differential TAM receptor–ligand–phospholipid interactions delimit differential TAM bioactivities
- (2014) Erin D Lew et al. eLife
- Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma
- (2013) I. Ben-Batalla et al. BLOOD
- T Cell-Derived Protein S Engages TAM Receptor Signaling in Dendritic Cells to Control the Magnitude of the Immune Response
- (2013) Eugenio A. Carrera Silva et al. IMMUNITY
- MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis
- (2013) Rebecca S. Cook et al. JOURNAL OF CLINICAL INVESTIGATION
- Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
- (2013) A B Lee-Sherick et al. ONCOGENE
- AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells
- (2013) M K Asiedu et al. ONCOGENE
- The receptor tyrosine kinase Axl regulates cell–cell adhesion and stemness in cutaneous squamous cell carcinoma
- (2013) M A Cichoń et al. ONCOGENE
- Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer
- (2013) L. Bosurgi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer
- (2012) R M A Linger et al. ONCOGENE
- Phosphoproteomic Screen Identifies Potential Therapeutic Targets in Melanoma
- (2011) K. Tworkoski et al. MOLECULAR CANCER RESEARCH
- A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells
- (2011) Kim J. Png et al. NATURE
- Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology
- (2011) A E J Rogers et al. ONCOGENE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Constitutive exposure of phosphatidylserine on viable cells
- (2011) K. Segawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
- (2010) S. J. Holland et al. CANCER RESEARCH
- Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity
- (2010) A. K. Keating et al. MOLECULAR CANCER THERAPEUTICS
- An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies
- (2010) X Ye et al. ONCOGENE
- Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer
- (2010) K Vuoriluoto et al. ONCOGENE
- Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
- (2009) C. Gjerdrum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development
- (2008) I.-K. Park et al. BLOOD
- Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-κB and Brg-1
- (2008) K-Y Tai et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started